Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244672 | SCV000313388 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001683091 | SCV001900042 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278201 | SCV002566318 | benign | Ehlers-Danlos syndrome | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379082 | SCV002670457 | benign | Cardiovascular phenotype | 2019-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |